Alpha Omega Wealth Management’s AstraZeneca AZN Stock Holding History

Alpha Omega Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$17K	–	233
2019 Q2	$17K	Hold	200	–	–	0.01%	387
2019 Q1	$16K	Hold	200	–	–	0.01%	376
2018 Q4	$15K	Hold	200	–	–	0.01%	326
2018 Q3	$16K	Hold	200	–	–	0.01%	332
2018 Q2	$14K	Sell	200 -50	-20%	-$3.6K	0.01%	347
2018 Q1	$17K	Hold	250	–	–	0.01%	302
2017 Q4	$17K	Hold	250	–	–	0.01%	303
2017 Q3	$17K	Hold	250	–	–	0.01%	306
2017 Q2	$17K	Hold	250	–	–	0.01%	300
2017 Q1	$16K	Hold	250	–	–	0.01%	304
2016 Q4	$14K	Hold	250	–	–	0.01%	316
2016 Q3	$16K	Hold	250	–	–	0.01%	150
2016 Q2	$15K	Hold	250	–	–	0.01%	153
2016 Q1	$14K	Hold	250	–	–	0.01%	151
2015 Q4	$17K	Buy	+250	New	+$16.4K	0.01%	139

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Alpha Omega Wealth Management's AZN Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of AstraZeneca (AZN) in Q3 2019, closing a stake of 200 shares — an estimated $17K sold.

Alpha Omega Wealth Management first reported a position in AZN in Q4 2015 and held it in 15 quarters. The position peaked at $17K in Q2 2019. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Alpha Omega Wealth Management reported no remaining AstraZeneca position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 200 AstraZeneca shares in Q3 2019, an estimated $17K.
Alpha Omega Wealth Management first reported a position in AstraZeneca in Q4 2015 and held it in 15 quarters.
Alpha Omega Wealth Management's AstraZeneca position peaked at $17K in Q2 2019.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.